Application 212515
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212515-001 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | AB2 | 2023-06-06 | 3f0d92c62455… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212515-001 | TADALAFIL | 20MG | TABLET / ORAL | 2023-06-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212515-001 | AB2 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212515-001 | AB2 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212515-001 | AB2 | 1 | 3f0d92c62455… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 30ae58ed-5b56-4513-8eb3-eb4f89b78f9d | 2023-03-22 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | ANI Pharmaceuticals, Inc. | 1dace1e7-c617-492f-bb0d-141bf4e673db | 2023-03-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | aa345972-40b4-415e-acb5-31b808a8d815 | 2023-03-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Proficient Rx LP | ac93704f-8e33-43ba-8b56-3d61092ff1d9 | 2023-01-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Burel Pharmaceuticals, LLC | a2e7f393-5cfc-45e5-b87d-9e8abc8e4355 | 2022-12-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 7a105ef9-7129-4ce1-bd8d-ae316bf348e2 | 2022-11-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADLIQ | TADALAFIL | CMP Pharma, Inc. | 7a909b25-3772-403e-a5fe-e4a040293fb7 | 2022-10-15 | Warnings, Adverse reactions | TADALAFIL |
| Tadalafil | TADALAFIL | Macleods Pharmaceuticals Limited | 93dd604f-8f38-4600-afe8-0fcc92fd2497 | 2022-09-27 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | b539e862-d5d4-4989-a3dd-1eba66285d53 | 2022-05-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 31c05a53-7282-46d0-81bd-108defe6fb38 | 2022-04-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 6fa9d4fa-86c9-4791-b28b-78e8b9341cea | 2022-04-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | aba646fe-70c2-1abb-e053-2995a90aa16d | 2022-01-28 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Qilu Pharmaceutical Co., Ltd. | f295f164-78fb-4224-b319-9f20b7a453b5 | 2021-11-17 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | VKT Pharma Private Limited | b4d9851c-5c06-4532-bd82-16d92b60c28f | 2021-11-17 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Cipla USA Inc. | cf6fc925-ad20-4ed0-9356-15d24afa8d0b | 2020-10-21 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 36350106-98bc-41fc-bede-8be5e6f54a8a | 2020-10-02 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Dr.Reddys Laboratories Inc | 61955171-ca57-e300-1983-9472a56ca976 | 2020-09-30 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Dr.Reddys Laboratories Inc | 22b8a2e3-d1b8-f193-45fa-77cc62a1b941 | 2020-01-30 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Amneal Pharmaceuticals NY LLC | 2cad2167-dbd1-4df8-b407-b270487d027b | 2019-10-25 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Camber Pharmaceuticals, Inc. | a3892605-4eb1-4d6e-a675-f7f7d4302f38 | 2019-03-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.